Blackstone (NYSE:BX) today announced the appointment of Jeffrey B. Kindler, former Chairman and CEO of Pfizer and current CEO of Centrexion Therapeutics, as a Senior Advisor. Mr. Kindler will bring his deep management experience and wide-ranging expertise in the healthcare sector to advise across the firm’s businesses and portfolio companies, with a focus on Blackstone Tactical Opportunities (Tac Opps) and Blackstone Growth (BXG).